Published in Biotech Business Week, January 22nd, 2007
Data from this open-label, proof-of-concept, single-site study demonstrate that Oxycyte increases brain oxygen tension and glucose metabolism compared to baseline, and favorably affects other brain chemistries that impact clinical outcomes in patients with traumatic brain injury. These data were compiled and analyzed by Virginia Commonwealth University.
Due to a technical malfunction whereby a complete measurement of oxygen levels in the brain of one treated patient...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.